Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Avignon
Clinical trial register · France

Clinical Trials in Avignon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9698 matching records held by the registry are in this view. Synced 23 Oct 2026, 03:20 UTC
9698
Studies in scope
all four open statuses
6023
Recruiting now
open to new participants
1034
Lead sponsors
across recruiting studies
Top sites
Paris 2820 Lyon 1390 Bordeaux 1389 Marseille 1285 Lille 1283
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca27 UNICANCER27 The Lymphoma Academic Research Organisation11 Intergroupe Francophone de Cancerologie Thoracique8 Hoffmann-La Roche7
Site location
Paris2820 Lyon1390 Bordeaux1389 Marseille1285 Lille1283
All 803 locations
Target enrolment
to

Trials with a site in Avignon

247 of 9698 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Assistance Publique Hopitaux De Marseille
Phase 4
224
Amiens, Avignon, Besançon, Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille
2027-01
Not yet open
University Hospital, Clermont-Ferrand
Phase 4
240
Amiens, Avignon, Bayonne, Clermont-Ferrand, La Roche-sur-Yon, Montpellier, Nancy, Nîmes
2026-12-01
Not yet open
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
320
Avignon, Clermont-Ferrand, Grenoble, Le Puy-en-Velay, Lyon, Montpellier, Paris, Saint-Etienne
2026-12
Not yet open
The Lymphoma Academic Research Organisation
Phase 2
95
Lyon, Argenteuil, Avignon, Bayonne, Bordeaux, Cergy-Pontoise, Corbeil-Essonnes, Estaing
2026-12
Not yet open
AbbVie
Phase 3
520
Nice, Tours, Vandœuvre-lès-Nancy, Nantes, Avignon
2026-11-30
Not yet open
Institut Cancerologie de l'Ouest
Not applicable
167
Angers, Avignon, Brest, La Roche-sur-Yon, Le Havre, Le Mans, Lorient, Rennes
2026-10
Not yet open
University Hospital, Montpellier
Phase 3
366
Amiens, Angers, Avignon, Besançon, Béziers, Bordeaux, Brest, Caen
2026-10
Recruiting
Volta Medical
Not applicable
125
Avignon, Bron, Dijon, Marseille, Strasbourg
2026-09-22
Not yet open
Philippe ROUSSELOT
Phase 2
93
Aix-en-Provence, Amiens, Angers, Argenteuil, Avignon, Bayonne, Besançon, Bobigny
2026-09-01
Recruiting
Centre Hospitalier Henri Duffaut - Avignon
Not applicable
80
Avignon
2026-08-31
Recruiting
Skipping Hormone Therapy in Low-Risk Early Breast Cancer
NCT07661927Breast Cancer (Early Breast Cancer)
UNICANCER
Phase 2
700
Angers, Avignon, Bayeux, Bayonne, Bordeaux, Boulogne-sur-Mer, Brest, Briis-sous-Forges
2026-07-06
Not yet open
The Lymphoma Academic Research Organisation
Observational
129
Amiens, Angers, Avignon, Besançon, Clermont-Ferrand, Créteil, Dijon, La Roche-sur-Yon
2026-06-30
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Auxerre, Avignon, Bayonne, Beauvais, Blois, Bobigny, Bordeaux, Bourg-en-Bresse
2026-06-26
Recruiting
Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer
NCT07455942Squamous Cell Carcinoma of the Anal Canal, HPV-induced Cancer
Centre Hospitalier Intercommunal Creteil
Observational
300
Angers, Avignon, Bayonne, Beuvry, Château-Gontier, Cholet, Créteil, Épagny
2026-06-23
Not yet open
Centre Hospitalier Henri Duffaut - Avignon
Not applicable
30
Avignon
2026-06-15
Recruiting
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
NCT07436312Breast Cancer, Pancreas Cancer, Colon Cancer, Lynch Syndrome
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
170
Avignon, Rennes, Villejuif
2026-05-04
Recruiting
Centre Hospitalier Henri Duffaut - Avignon
Not applicable
285
Avignon
2026-04-08
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
126
Aix-en-Provence, Amiens, Angers, Avignon, Besançon, Bordeaux, Boulogne-Billancourt, Caen
2026-04-02
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Phase 3
129
Angers, Avignon, Besançon, Boulogne, Caen, Chambray-lès-Tours, Dijon, Grenoble
2026-02-06
Not yet open
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
120
Dijon, Montpellier, Rennes, Saint-Herblain, Lille, Villeurbanne, Rouen, Avignon
2026-01-15
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
390
Angers, Avignon
2026-01-12
Recruiting
Institut Curie
Not applicable
450
Avignon, Bordeaux, Clermont-Ferrand, Lyon, Marseille, Montpellier, Nîmes, Paris
2026-01-05
Recruiting
AstraZeneca
Phase 3
1,100
Amiens, Avignon, Nîmes, Paris, Pau, Pierre-Bénite, Plerin SUR MER, Reims
2025-12-29
Recruiting
Eli Lilly and Company
Phase 3
800
Avignon, Besançon, Brest, Clermont-Ferrand, Dijon, Le Mans, Lyon, Montpellier
2025-12-22
Recruiting
Nantes University Hospital
Observational
50
Angers, Annecy, Avignon, La Roche-sur-Yon, Lille, Nantes, Orléans, Poitiers
2025-12-19
Recruiting
UNICANCER
Phase 3
3,902
Amiens, Angers, Argenteuil, Aurillac, Auxerre, Avignon, Bayonne, Beauvais
2025-12-18
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
324
Aurillac, Avignon, Bayeux, Bayonne, Bezannes, Bordeaux, Brest, Caen
2025-12-15
Recruiting
French Innovative Leukemia Organisation
Phase 2
33
Amiens, Angers, Argenteuil, Avignon, Besançon, Clamart, Clermont-Ferrand, Corbeil-Essonnes
2025-12-11
Recruiting
Incyte Corporation
Phase 3
466
Avignon, Bordeaux, Chambray-lès-Tours, La Roche-sur-Yon, La Tronche, Lyon, Marseille, Nice
2025-12-09
Recruiting
Janssen Research & Development, LLC
Phase 3
500
Avignon, Le Mans, Lille, Marseille, Paris, Rouen, Saint-Herblain, Villejuif
2025-12-03
Recruiting
University of Avignon
Observational
160
Avignon, Montpellier
2025-12-01
Recruiting
Glofitamab in Real Life
NCT06994169Large B-cell Lymphoma
DrugGlofitamab
The Lymphoma Academic Research Organisation
Observational
250
Argenteuil, Avignon, Bayonne, Besançon, Clamart, Créteil, Dijon, Dunkirk
2025-12-01
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Avignon, Bron, Créteil, Le Mans, Limoges, Lyon, Montpellier, Pierre-Bénite
2025-11-30
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Avignon, Epagny Metz-Tessy, Le Mans
2025-11-28
Recruiting
Nantes University Hospital
Not applicable
686
Angers, Angoulème, Argenteuil, Nantes, Arles, Avignon, Belfort, Bordeaux
2025-11-11
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
152
Angers, Avignon, Boulogne, Brest, Caen, Créteil, Dijon, Le Mans
2025-11-07
Recruiting
UNICANCER
Phase 2
72
Amiens, Angers, Avignon, Besançon, Bordeaux, Caen, Clermont-Ferrand, Clichy
2025-10-09
Recruiting
University Hospital, Clermont-Ferrand
Phase 2
95
Annecy, Amiens, Avignon, Bayonne, Besançon, Beuvry, Brest, Caen
2025-10-07
Recruiting
Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
NCT07028125Renal Cell Carcinoma (Kidney Cancer), Metastatic Renal Cell Carcinoma, Locally Advanced
Centre Francois Baclesse
Phase 4
83
Annecy, Avignon, Bayeux, Boulogne-sur-Mer, Caen, Coudekerque-Branche, Creil, Dijon
2025-10-01
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
124
Creil, Avignon, Villejuif
2025-09-09
Not yet open
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
60
Avignon, Besançon, Levallois-Perret, Lyon, Paris, Pessac, Poitiers, Toulouse
2025-09
Recruiting
BeOne Medicines
Phase 3
351
Avignon, Brest, Lille
2025-08-27
Recruiting
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Phase 1
15
Avignon, Besançon, Brest, Lille, Lyon, Pessac, Poitiers, Reims
2025-08-08
Recruiting
AstraZeneca
Phase 2
278
Avignon, Paris, Rennes, Saint-Herblain, Suresnes
2025-08-07
Recruiting
AstraZeneca
Phase 3
800
Avignon, Besançon, Bordeaux, Chambray-lès-Tours, Cholet, Créteil, Grenoble, Lille
2025-08-01
By invitation
UNICANCER
Phase 2
80
Amiens, Auxerre, Avignon, Bayonne, Beauvais, Blois, Boulogne-sur-Mer, Brest
2025-07-30
Recruiting
Intergroupe Francophone du Myelome
Phase 3
824
Amiens, Angers, Annecy, Argenteuil, Avignon, Bayonne, Besançon, Blois
2025-07-09
Recruiting
Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
NCT07243132Metastatic Lung Cancer, Metastatic NSCLC, Metastatic Small Cell Lung Cancer
GFPC Investigation
Observational
1,000
Aix-en-Provence, Angers, Avignon, Bastia, Bobigny, Brest, Bron, Caen
2025-07-02
Recruiting
AstraZeneca
Phase 3
830
Angers, Avignon, Boulogne-Billancourt, Caen, Chambéry, Dijon, La Tronche, Limoges
2025-04-10
Recruiting
Daiichi Sankyo
Phase 3
510
Avignon, Brest, Dijon, Montpellier, Paris, Poitiers, Rennes, Strasbourg
2025-03-27
Recruiting
UNICANCER
Phase 2
73
Amiens, Angers, Avignon, Besançon, Cholet, Dijon, Lyon, Montpellier
2025-03-21
Recruiting
UNICANCER
Phase 2
220
Amiens, Avignon, Bayonne, Besançon, Bordeaux, Caen, Dijon, La Roche-sur-Yon
2025-03-11
Recruiting
Daiichi Sankyo
Phase 3
726
Avignon, Brest, Dijon, Grenoble, Lille, Lyon, Montpellier, Nantes
2025-02-27
Recruiting
Summit Therapeutics
Phase 3
780
Nantes, Avignon, Brest, Créteil, Lille, Lyon, Marseille, Paris
2025-02-27
Recruiting
Centre Hospitalier Henri Duffaut - Avignon
Not applicable
120
Avignon
2025-02-10
Recruiting
UNICANCER
Phase 2
400
Amiens, Aurillac, Avignon, Bayeux, Bayonne, Besançon, Caen, Caluire-et-Cuire
2025-01-20
Recruiting
Pfizer
Not applicable
90
Paris, Aix-en-Provence, Albi, Amiens, Avignon, Bordeaux, Brest, Créteil
2025-01-20
Recruiting
Elsan
Not applicable
510
Avignon, Besançon, Bordeaux, Cabestany, Caen, Le Mans, Nancy, Ollioules
2024-12-30
Recruiting
UNICANCER
Phase 2
354
Amiens, Avignon, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Dijon, Levallois-Perret
2024-12-27
Recruiting
UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
NCT06726720Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
AstraZeneca
Observational
300
Aix-en-Provence, Angers, Aurillac, Auxerre, Avignon, Bezannes, Béziers, Blois
2024-12-16
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Avignon, Pessac, Poitiers
2024-12-12
Active, closed
ARCAGY/ GINECO GROUP
Phase 2
77
Angers, Avignon, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Créteil
2024-12-11
Recruiting
AstraZeneca
Phase 3
1,160
Avignon, La Rochelle, Lyon, Nîmes, Rennes, Strasbourg, Suresnes, Toulon
2024-11-27
Active, closed
Genmab
Phase 3
191
Marseille, Bordeaux, Bayonne, Avignon, Villejuif, Angers, Boulogne-Billancourt, Créteil
2024-11-25
Active, closed
Institut Sainte Catherine
Phase 4
100
Avignon
2024-11-18
Recruiting
AstraZeneca
Phase 3
1,160
Avignon, La Rochelle, Lyon, Nîmes, Rennes, Strasbourg, Suresnes, Toulon
2024-11-18
Active, closed
Institut Claudius Regaud
Phase 2
86
Amiens, Avignon, Bordeaux, Clermont-Ferrand, Limoges, Marseille, Nantes, Nice
2024-10-21
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Avignon, Lille, Lyon, Montpellier, Nantes, Paris, Pessac, Poitiers
2024-10-18
Recruiting
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NCT06446882HER2-positive Breast Cancer, Early-stage Breast Cancer
Fundacio Clinic Barcelona
Not applicable
304
Avignon, Bordeaux, Léon, Marseille, Nancy, Paris, Toulouse
2024-10-11
Recruiting
GFPC Investigation
Phase 4
500
Aix-en-Provence, Avignon, Bastia, Brest, Caen, Chambéry, Cherbourg, Clermont-Ferrand
2024-09-26
Active, closed
Genmab
Phase 3
379
Strasbourg, Caen, Tours, Avignon, Bayonne, Poitiers, Lille
2024-08-13
Recruiting
ARCAGY/ GINECO GROUP
Phase 3
250
Angers, Avignon, Bayonne, Besançon, Bordeaux, Brest, Caen, Chambray-lès-Tours
2024-07-30
Recruiting
Hospices Civils de Lyon
Phase 4
140
Avignon, Bobigny, Créteil, Dijon, Lille, Limoges, Lyon, Montpellier
2024-07-30
Recruiting
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
NCT06333314Pancreatic Adenocarcinoma, Ampulla of Vater Carcinoma, Adrenocortical Carcinoma, Neuroendocrine Carcinoma
DrugDostarlimab
UNICANCER
Phase 2
120
Angers, Avignon, Besançon, Brest, Caen, Clermont-Ferrand, Créteil, Dijon
2024-07-23
Recruiting
UNICANCER
Phase 3
800
Amiens, Angers, Avignon, Besançon, Bordeaux, Caen, Clermont-Ferrand, Créteil
2024-07-18
Recruiting
Institut Sainte Catherine
Not applicable
100
Avignon
2024-07-16
Recruiting
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
NCT06393816Large Cell Neuroendocrine Carcinoma of the Lung
DrugDurvalumab
Centre Leon Berard
Phase 2
80
Aix-en-Provence, Amiens, Angers, Avignon, Brest, Caen, Clermont-Ferrand, Créteil
2024-06-13
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Marseille, Vantoux, Angers, Avignon, La Roche-sur-Yon, Paris
2024-06-10
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Avignon, Bayonne, Besançon, Bordeaux, Cahors, Chambéry, Clermont-Ferrand, Créteil
2024-06-07
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Nice, Dijon, Nîmes, Valenciennes, Clermont-Ferrand, Avignon, Boulogne-Billancourt
2024-05-24
Recruiting
Daiichi Sankyo
Phase 3
540
Avignon, Bordeaux, Créteil, Lille, Limoges, Lyon, Marseille, Montpellier
2024-05-21
Active, closed
AbbVie
Phase 3
421
Saint-Quentin, Orléans, Le Mans, Avignon
2024-05-19
Recruiting
Janssen Research & Development, LLC
Phase 1/2
287
Avignon, Lille, Nantes, Paris, Villejuif
2024-04-22
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
120
Angers, Avignon, Besançon, Bordeaux, Brest, Caen, Cholet, Clermont-Ferrand
2024-04-16
Recruiting
CARE1 Pragmatic Clinical Trial
NCT06364631Metastatic Kidney Cancer, Metastatic Kidney Carcinoma
DrugsAxitinib·Cabozantinib·Yervoy·Ipilimumab
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,250
Angers, Avignon, Bayonne, Besançon, Bordeaux, Caen, Chalon-sur-Saône, Clermont-Ferrand
2024-04-12
Recruiting
UNICANCER
Phase 2
420
Saint-Denis, Avignon, Dijon, Lille, Marseille, Nice, Nîmes, Paris
2024-04-03
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
212
Avignon, Lyon, Marseille, Mâcon, Nice, Saint-Etienne, Saint-Herblain, Villejuif
2024-03-26
Active, closed
Novartis Pharmaceuticals
Observational
201
Angers, Limoges, Saint Priest Jarez, Aix-en-Provence, Amiens, Antibes, Avignon, Besançon
2024-03-06
Active, closed
Genmab
Phase 3
1,095
Caen, Brest, Nantes, Avignon, Pierre-Bénite, Le Mans, Libourne, Paris
2024-02-05
Not yet open
Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes
NCT06155942Parkinson Disease, Progressive Supranuclear Palsy
Assistance Publique Hopitaux De Marseille
Not applicable
63
Aix-en-Provence, Aubagne, Avignon, Nice, Nîmes, Toulon
2024-01-15
Recruiting
NovoCure Ltd.
Observational
430
Amiens, Avignon, Bordeaux, Brest, Bron, Caen, Clermont-Ferrand, Dijon
2024-01-11
Recruiting
Eli Lilly and Company
Phase 3
1,264
Avignon, Bron, Lille, Lyon Cedex08, Nice, Paris, Pessac, Poitiers
2023-12-21
Active, closed
University Hospital, Lille
Phase 2
74
Amiens, Angers, Avignon, Bayonne, Besançon, Caen, Dijon, La Tronche
2023-12-21
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Strasbourg, Grenoble, St-Malo, Mulhouse, Boulogne-sur-Mer, Poitiers, Avignon, Marseille
2023-12-20
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
44
Angers, Avignon, Caen, Lyon
2023-12-20
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Avignon, Besançon, Clichy, Levallois-Perret, Lyon, Montpellier, Paris, Villejuif
2023-12-20
Recruiting
Institut Curie
Phase 2
66
Clermont-Ferrand, Amiens, Avignon, Caen, Dijon, Lille, Montpellier, Nantes
2023-12-19
Recruiting
AstraZeneca
Phase 3
1,145
Avignon, Bordeaux, Le Mans, Lyon, Nice, Saint-Herblain, Toulouse, Villejuif
2023-12-14
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Angers, Avignon, Besançon, Caen, Clermont-Ferrand, La Rochelle, Lille, Lyon
2023-12-11
Recruiting
Centre Hospitalier Henri Duffaut - Avignon
Not applicable
60
Avignon
2023-11-29
Active, closed
Sanofi
Observational
303
Amiens, Angers, Argenteuil, Armentières, Arras, Ars-Laquenexy, Avignon, Besançon
2023-11-28
Active, closed
AstraZeneca
Phase 3
1,902
Avignon, Bayonne, Caen, Clermont-Ferrand, Limoges, Marseille, Montpellier, Nice
2023-11-14
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 4
600
Argenteuil, Avignon, Bordeaux, Boulogne-Billancourt, Clermont-Ferrand, Clichy, Étampes, La Roche-sur-Yon
2023-11-13
Recruiting
LeonaBio
Phase 3
600
Avignon, Besançon, Bordeaux, Caen, Le Mans, Lille, Lyon, Marseille
2023-10-31
Active, closed
AstraZeneca
Phase 3
895
Angers, Avignon, Bayonne, Bordeaux, Caen, Lille, Limoges, Marseille
2023-10-24
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Amiens, Antony, Arras, Avignon, Bayonne, Besançon, Bordeaux, Bourg-en-Bresse
2023-10-24
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
500
Avignon
2023-10-18
Active, closed
PRostate Olaparib Real World Evidence Study
NCT06031805Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Observational
159
Amiens, Angers, Antony, Argenteuil, Avignon, Besançon, Bordeaux, Challes-les-Eaux
2023-10-11
Recruiting
Hoffmann-La Roche
Phase 3
230
Avignon, Bayonne, Bordeaux, Dijon, Lille
2023-09-08
Recruiting
The Lymphoma Academic Research Organisation
Phase 3
260
Nancy, Amiens, Avignon, Bayonne, Besançon, Bordeaux, Clermont-Ferrand, Créteil
2023-09-05
Recruiting
iVascular S.L.U.
Observational
209
Avignon, Carpentras, Niort, Plérin, Toulon
2023-08-01
Recruiting
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
NCT05639413Metastatic Colorectal Cancer, BRAF V600E Mutation Positive
UNICANCER
Not applicable
400
Avignon, Bayeux, Beauvais, Bordeaux, Bourg-en-Bresse, Cahors, Calais, Caluire-et-Cuire
2023-07-24
Active, closed
UNICANCER
Phase 2
118
Amiens, Arras, Avignon, Beauvais, Besançon, Brest, Cholet, Clermont-Ferrand
2023-06-23
Recruiting
Hoffmann-La Roche
Phase 3
420
Avignon, Bayonne, Bordeaux, Lyon, Montpellier, Rennes, Toulouse
2023-06-07
Active, closed
Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus
NCT05825573Intracardiac Thrombus, STEMI, Heart Failure
DrugDirect Anticoagulant
Centre Hospitalier Universitaire de Nīmes
Phase 3
340
Angers, Auxerre, Avignon, Bastia, Bordeaux, Brest, Chartres, Clermont-Ferrand
2023-05-15
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
248
Amiens, Angers, Avignon, Besançon, Béziers, Bobigny, Caen, Clamart
2023-05-03
Active, closed
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
156
Amiens, Angers, Avignon, Bayonne, Besançon, Bordeaux, Boulogne, Caen
2023-04-26
Active, closed
Hoffmann-La Roche
Phase 2
199
Avignon, Besançon, Bordeaux, Caen, Lyon, Villejuif
2023-04-21
Recruiting
Institut Curie
Not applicable
50
Tours, Avignon, Bordeaux, Clermont-Ferrand, Grenoble, Lille, Lyon, Montpellier
2023-04-08
Recruiting
AstraZeneca
Phase 3
4,300
Angers, Argenteuil, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Cholet, Clermont-Ferrand
2023-03-31
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
60
Angers, Avignon, Lyon
2023-03-27
Active, closed
UNICANCER
Phase 2
100
Aix-en-Provence, Avignon, Bayonne, Caen, Clermont-Ferrand, Créteil, Dijon, Lille
2023-03-24
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Avignon, Besançon, Béziers, Bobigny, Bordeaux, Caen, Compiègne, Dijon
2023-03-09
Active, closed
Pfizer
Phase 3
624
Dijon, Montpellier, Saint-Herblain, Angers, Clermont-Ferrand, Avignon, Poitiers, Créteil
2023-03-03
Recruiting
Institut Bergonié
Phase 2
62
Avignon, Besançon, Bordeaux, Brest, Marseille, Paris, Saint-Grégoire, Saint-Herblain
2023-02-24
Recruiting
Poitiers University Hospital
Not applicable
670
Angers, Argenteuil, Aurillac, Avignon, Belfort, Bordeaux, Bourg-en-Bresse, Brest
2023-02-02
Active, closed
Daiichi Sankyo
Phase 3
1,170
Avignon, Besançon, Bordeaux, France, Lyon, Marseille, Montpellier, Nantes
2023-01-11
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Avignon, Brest, Caen, Chambray-lès-Tours, Cholet, Contamine-sur-Arve, Lyon, Nantes
2022-12-16
Recruiting
Recherche clinique
Not applicable
15
Avignon
2022-12-01
Active, closed
AstraZeneca
Observational
254
Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Clermont-Ferrand, Créteil, Dijon
2022-11-14
Active, closed
French Innovative Leukemia Organisation
Observational
1,000
Amiens, Angers, Annecy, Argenteuil, Avignon, Besançon, Béziers, Blois
2022-11-11
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Angers, Avignon, Bayonne, Bordeaux, Caen, Chambéry, Cholet, Créteil
2022-10-27
Recruiting
Regeneron Pharmaceuticals
Observational
500
Mulhouse, Strasbourg, Marseille, Avignon, Poitiers, Angers, Clermont-Ferrand, Le Mans
2022-10-26
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Besançon, Avignon, Brest, Clermont-Ferrand, Créteil, Dijon, Lyon, Marseille
2022-10-24
Active, closed
Centre Georges Francois Leclerc
Phase 1/2
160
Dijon, Angers, Avignon, Besançon, Bordeaux, Carcassonne, Clermont-Ferrand, Levallois-Perret
2022-10-13
Active, closed
Eli Lilly and Company
Phase 3
8,000
Avignon, Bayonne, Besançon, Bordeaux, Brest, Clermont-Ferrand, Créteil, La Chaussée-Saint-Victor
2022-10-04
Active, closed
National Acalabrutinib Observational Study
NCT05437250Chronic Lymphocytic Leukemia
DrugNon-Interventional Study
AstraZeneca
Observational
350
Aix-en-Provence, Amiens, Angers, Ars-Laquenexy, Avignon, Besançon, Béziers, Bobigny
2022-09-13
Recruiting
TARGETed Therapy Drug MONITOring in DIGestive Oncology
NCT05443087Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma, GIST
UNICANCER
Not applicable
330
Amiens, Auxerre, Avignon, Bayeux, Clermont-Ferrand, Clichy, Dijon, Évreux
2022-08-29
Recruiting
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
NCT05198661Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis
Hospices Civils de Lyon
Not applicable
3,500
Pointe à Pitre, Aix-en-Provence, Amiens, Angers, Annecy, Avignon, Bayonne, Besançon
2022-08-02
Recruiting
Hospices Civils de Lyon
Not applicable
204
Amiens, Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Chambéry, Clermont-Ferrand
2022-08-01
Active, closed
Gilead Sciences
Phase 3
443
Avignon, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Lyon, Marseille
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
Avignon, Besançon, Brest, Caen, Clermont-Ferrand, Montpellier, Nantes, Pierre-Bénite
2022-07-20
Active, closed
Hoffmann-La Roche
Phase 3
922
Avignon, Bayonne, Besançon, Bordeaux, Grenoble, La Roche-sur-Yon, Lyon, Paris
2022-07-18
Recruiting
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
NCT05198960Polycythemia Vera, Essential Thrombocythemia, Prefibrotic/Early Primary Myelofibrosis, JAK2 V617F
DrugAspirin
University Hospital, Brest
Phase 3
1,308
Angers, Annecy, Argenteuil, Avignon, Bayonne, Béziers, Bordeaux, Brest
2022-07-13
Active, closed
French Innovative Leukemia Organisation
Phase 2
134
Angers, Annecy, Avignon, Bayonne, Besançon, Béziers, Clermont-Ferrand, Grenoble
2022-05-25
Recruiting
Groupe Francophone des Myelodysplasies
Phase 1/2
150
Amiens, Angers, Argenteuil, Avignon, Bayonne, Bobigny, Cesson-Sévigné, Compiègne
2022-05-18
Active, closed
SOLTI Breast Cancer Research Group
Phase 2
1,100
Avignon, Bayonne, Besançon, Blois, Caen, Cholet, Clermont-Ferrand, Dijon
2022-05-03
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Phase 2/3
1,360
Aix-en-Provence, Amiens, Angers, Avignon, Besançon, Bordeaux, Caen, Cannes
2022-05-02
Recruiting
UNICANCER
Phase 3
300
Avignon, Bayonne, Besançon, Beuvry, Bordeaux, Brest, Caen, Chambéry
2022-04-19
Active, closed
ARCAGY/ GINECO GROUP
Phase 3
260
Amiens, Angers, Auxerre, Avignon, Beauvais, Besançon, Bordeaux, Brest
2022-04-15
Recruiting
AstraZeneca
Phase 2
630
Avignon, Bobigny, Bordeaux, Limoges, Rennes, Rouen, Suresnes, Toulon
2022-04-14
Recruiting
Royal Marsden NHS Foundation Trust
Phase 2
1,100
Angers, Annecy, Avignon, Blois, Bordeaux, Clermont-Ferrand, Dijon, Grenoble
2022-03-30
Recruiting
AbbVie
Phase 3
768
Marseille, Lille, Montpellier, Pessac, Paris, Avignon, Bron, Lyon
2022-03-25
Active, closed
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT05078047Lung Cancer Metastatic, Renal Cell Carcinoma, Head and Neck Cancer, Triple Negative Breast Cancer
UNICANCER
Phase 3
646
Angers, Avignon, Bayonne, Bordeaux, Boulogne-sur-Mer, Caen, Clermont-Ferrand, Créteil
2022-03-08
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Rouen, Bordeaux, Montpellier, Saint-Herblain, Avignon, Dijon, Besançon, Bobigny
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Avignon, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2022-03-04
Active, closed
AstraZeneca
Phase 3
1,051
Avignon, Besançon, Bordeaux, Clermont-Ferrand, Créteil, Lorient, Marseille, Montpellier
2022-02-07
Recruiting
ARCAGY/ GINECO GROUP
Phase 2
390
Angers, Avignon, Besançon, Bordeaux, Brest, Bron, Caen, Cholet
2022-02-01
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
210
Angers, Avignon, Bayonne, Besançon, Brest, Caen, Clermont-Ferrand, Créteil
2022-01-24
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
71
Avignon, Bayonne, Besançon, Bordeaux, Corbeil-Essonnes, La Roche-sur-Yon, Lille, Limoges
2021-12-20
Active, closed
Intergroupe Francophone du Myelome
Phase 3
791
Amiens, Angers, Argenteuil, Avignon, Bayonne, Besançon, Blois, Bobigny
2021-12-08
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Pessac, Avignon, Bordeaux, Dijon, Grenoble, Lyon, Nantes, Poitiers
2021-12-02
Recruiting
UNICANCER
Phase 3
102
Avignon, Besançon, Bordeaux, Caen, Carcassonne, Clermont-Ferrand, Dijon, Le Havre
2021-12-01
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Avignon, Bron, La Tronche, Le Mans, Lille, Marseille, Montpellier, Paris
2021-11-17
Active, closed
Gilead Sciences
Phase 3
603
Avignon, Bayonne, Boulogne-Billancourt, Caen, Calvados, Chauny, Clermont-Ferrand, Créteil
2021-11-17
Active, closed
French Innovative Leukemia Organisation
Phase 2
160
Angers, Argenteuil, Avignon, Bayonne, Bobigny, Cesson-Sévigné, Clermont-Ferrand, Corbeil-Essonnes
2021-10-18
Active, closed
Fondazione Ricerca Traslazionale
Phase 2
105
Avignon, Cholet, Mulhouse, Strasbourg
2021-10-12
Active, closed
Study of Lacutamab in Peripheral T-cell Lymphoma
NCT04984837Peripheral T Cell Lymphoma, Relapse/Recurrence
DrugsOxaliplatine·Gemcitabine
The Lymphoma Academic Research Organisation
Phase 2
49
Amiens, Angers, Avignon, Bayonne, Bordeaux, Caen, Chambéry, Clermont-Ferrand
2021-10-05
Active, closed
Institut Curie
Not applicable
364
Abbeville, Aix-en-Provence, Amiens, Angers, Ars-Laquenexy, Avignon, Boulogne-Billancourt, Compiègne
2021-09-24
Active, closed
Merck Sharp & Dohme LLC
Phase 2
730
Rennes, Besançon, Brest, Montpellier, La Tronche, Avignon, Clichy
2021-08-18
Active, closed
ARCAGY/ GINECO GROUP
Phase 2
180
Angers, Avignon, Bayonne, Besançon, Bordeaux, Caen, Chambray-lès-Tours, Cholet
2021-08-05
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Avignon, Bobigny, Bordeaux, Clermont-Ferrand, Clichy, Grenoble, Lyon, Marseille
2021-07-06
Active, closed
AstraZeneca
Phase 3
315
Avignon, Brest, Clermont-Ferrand, Dijon, Limoges, Lorient, Lyon, Marseille
2021-06-30
Active, closed
GlaxoSmithKline
Phase 3
40
Avignon, Bordeaux, Caen, Dijon, Marseille, Montpellier, Pierre-Bénite, Rouen
2021-06-28
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Chambray-lès-Tours, Avignon, Besançon, Bordeaux, Brest, Dijon, Lille, Lyon
2021-06-24
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
141
Avignon, Bayonne, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon
2021-06-11
Active, closed
Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE
NCT04993638Hip Arthropathy, Hip Osteoarthritis, Hip Arthritis, Hip Fractures
EUROS
Observational
147
Avignon, Clermont-Ferrand, Lyon
2021-06-01
Active, closed
Post Market Clinical Follow-up of EUROSTEM Femoral Stem
NCT04995822Hip Osteoarthritis, Hip Arthropathy, Hip Arthritis, Hip Necrosis
EUROS
Observational
131
Puilboreau, Agen, Aix-en-Provence, Arnas, Avignon, Dijon, Grasse, Guilherand-Granges
2021-05-21
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
96
Avignon, Besançon, Brest, Créteil, Dijon, Le Mans, Levallois-Perret, Lille
2021-05-21
Active, closed
AstraZeneca
Observational
274
Abbeville, Aix-en-Provence, Angers, Antibes, Avignon, Bastia, Bayonne, Bordeaux
2021-05-12
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Avignon, Besançon, Bordeaux, Brest, Caen, Creil, Lyon, Nîmes
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Angers, Avignon, Bordeaux, Clermont-Ferrand, Lyon, Nancy, Paris, Suresnes
2021-05-03
Active, closed
AstraZeneca
Phase 3
1,157
Avignon, Besançon, Bordeaux, Caen, Le Mans, Montpellier, Nice, Paris
2021-04-26
Active, closed
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
54
Aix-en-Provence, Angers, Annecy, Antony, Avignon, Bayonne, Bordeaux, Boulogne
2021-03-19
Recruiting
Elsan
Observational
2,000
Agen, Avignon, Beaumont, Besançon, Bordeaux, Brest, Brive-la-Gaillarde, Cabestany
2021-03-08
Active, closed
ENCOrafenib With Binimetinib in bRAF NSCLC
NCT04526782Non Small Cell Lung Cancer, BRAF V600E
DrugsBinimetinib·Encorafenib
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
119
Ambilly, Angers, Avignon, Bordeaux, Boulogne-Billancourt, Brest, Caen, Colmar
2021-01-19
Active, closed
AstraZeneca
Phase 3
358
Avignon, Bordeaux
2020-12-16
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
307
Avignon, Besançon, Bordeaux, Caen, Clichy, Creil, Dijon, Grenoble
2020-12-07
Active, closed
AstraZeneca
Phase 3
957
Avignon, Besançon, Brest, Dijon, Lyon, Montpellier, Nantes, Nice
2020-11-17
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
68
Avignon, Bobigny, Brest, Créteil, Villejuif
2020-11-17
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
DrugsXeloda·Sacituzumab Govitecan·Paraplatin·Capecitabine
GBG Forschungs GmbH
Phase 3
1,332
Angers, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Dijon, Lille
2020-10-28
Active, closed
AstraZeneca
Phase 3
370
Avignon, Bordeaux, Clermont-Ferrand, Dijon, Lyon, Marseille, Montpellier, Strasbourg
2020-10-02
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Angers, Avignon, Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Lyon
2020-09-23
Active, closed
AbbVie
Phase 3
531
Nice, Pessac, La Tronche, Lille, Nantes, Marseille, Rouen, Avignon
2020-09-10
Active, closed
Medtronic
Observational
2,200
Avignon, Metz-Tessy, Nantes, Saint-Priest-en-Jarez, Brest, Caen, Clermont-Ferrand, Dijon
2020-08-01
Active, closed
Medtronic
Observational
2,200
Avignon, Brest, Caen, Clermont-Ferrand, Dijon, La Rochelle, Nantes, Pringy
2020-08-01
Active, closed
AstraZeneca
Phase 3
866
Avignon, Besançon, Bordeaux, Brest, Caen, Dijon, Le Mans, Marseille
2020-07-24
Active, closed
UNICANCER
Phase 3
550
Avignon, Bordeaux, Brest, Caen, Clermont-Ferrand, Creil, Créteil, Jossigny
2020-06-23
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Avignon, Amiens, Paris
2020-05-19
Active, closed
KANDO Research
Not applicable
302
Bordeaux, Toulouse, Avignon, Paris
2020-02-18
Active, closed
Intergroupe Francophone du Myelome
Not applicable
395
Abbeville, Amiens, Angers, Annecy, Argenteuil, Arras, Auch, Avignon
2020-02-11
Active, closed
Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
NCT04070443Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia
DrugsPonatinib·Imatinib
Centre Leon Berard
Phase 2
170
Amiens, Angers, Annecy, Avignon, Besançon, Bordeaux, Brest, Caen
2019-11-13
Active, closed
UNICANCER
Not applicable
200
Angers, Avignon, Caen, Chalon-sur-Saône, Cholet, Clermont-Ferrand, Dijon, Lyon
2019-10-23
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
Avignon, Bordeaux, Caen, Cholet, Dijon, Limoges, Lorient, Lyon
2019-08-27
Recruiting
Hospices Civils de Lyon
Not applicable
146
Amiens, Angers, Avignon, Bar-le-Duc, Bobigny, Brest, Bron, Caen
2019-08-20
Recruiting
French Registry for Monitoring Pregnancies for Multiple Sclerosis
NCT03900221Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders, Pregnancy Abnormal
Hospices Civils de Lyon
Observational
1,500
Amiens, Annecy, Avignon, Besançon, Bordeaux, Brive-la-Gaillarde, Bron, Caen
2019-08-12
Active, closed
Intergroupe Francophone de Cancerologie Thoracique
Phase 3
510
Abbeville, Aix-en-Provence, Ambilly, Ars-Laquenexy, Auxerre, Avignon, Bayonne, Besançon
2019-07-23
Active, closed
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast
NCT03878342DCIS, Breast Cancer, Low Risk DCIS, Breast Conserving Surgery
UNICANCER
Not applicable
295
Angers, Avignon, Bayonne, Bordeaux, Caen, Cherbourg, Clermont-Ferrand, Créteil
2019-05-10
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Avignon, Besançon, Brest, Lyon, Montbéliard, Nice, Paris, Pessac
2019-03-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Caen, Dijon, Toulouse, Lille, Saint-Cloud, Montpellier, Metz, Avignon
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Nice, Marseille, Toulouse, Villejuif, Avignon, Paris
2018-12-17
Active, closed
AstraZeneca
Phase 3
825
Avignon, Lyon, Nice, Toulon, Vantoux
2018-12-06
Active, closed
Institut Cancerologie de l'Ouest
Not applicable
256
Avignon, Bordeaux, Brest, Chalon-sur-Saône, Clermont-Ferrand, Dijon, Lille, Lyon
2018-12-04
Active, closed
Tesaro, Inc.
Phase 3
1,400
Angers, Avignon, Besançon, Bordeaux, Bron, Caen, Cholet, Clermont-Ferrand
2018-10-11
Active, closed
Institut Paoli-Calmettes
Phase 2
52
Amiens, Avignon, Bordeaux, Caen, Dijon, Lyon, Paris, Rouen
2018-08-29
Active, closed
French Innovative Leukemia Organisation
Phase 2
120
Angers, Avignon, Bayonne, Besançon, Béziers, Brest, Castelnau-le-Lez, Clermont-Ferrand
2018-08-24
Active, closed
Centre Leon Berard
Phase 2
90
Avignon, Besançon, Clermont-Ferrand, Grenoble, Lyon, Pringy, Saint-Etienne, Sainte-Foy-lès-Lyon
2018-08-06
Active, closed
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
NCT03143322Metastatic Breast Cancer, Metastatic Lung Cancer, Metastatic Prostate Cancer, Bone Metastases
UNICANCER
Not applicable
168
Angers, Arras, Avignon, Beuvry, Bordeaux, Chambéry, Chambray-lès-Tours, Creil
2018-07-24
Recruiting
Centre Hospitalier Henri Laborit
Observational
2,000
Angers, Anglet, Avignon, Bayonne, Bégard, Caen, Clermont-Ferrand, Dijon
2018-04-24
Active, closed
Groupe Francophone des Myelodysplasies
Phase 3
124
Amiens, Angers, Avignon, Bayonne, Belfort, Besançon, Bobigny, Brest
2018-03-26
Active, closed
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
NCT03323476Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease
Centre Hospitalier Departemental Vendee
Phase 3
136
Amiens, Angers, Angoulême, Arras, Avignon, Avranches, Besançon, Bordeaux
2018-02-02
Active, closed
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
NCT03774732Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4
DrugPembrolizumab
UNICANCER
Phase 3
327
Angers, Arras, Avignon, Beuvry, Blois, Bordeaux, Brest, Caen
2018-01-24
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
57
Avignon, Besançon, Créteil, Levallois-Perret, Lyon, Nantes, Paris, Poitiers
2017-12-04
Active, closed
Medtronic
Observational
1,092
Avignon, Bayonne, Brest, Caen, Clermont-Ferrand, Dijon, La Rochelle, Marseille
2017-08-21
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Angers, Avignon, Bordeaux, Caen, Cholet, Clermont-Ferrand, Dijon, Lille
2017-06-21
Recruiting
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
NCT04220970Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
The Lymphoma Academic Research Organisation
Observational
150
Avignon, Bordeaux, Brest, Colmar, Créteil, Dijon, Lille, Lyon
2017-06-07
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Avignon, Besançon, Beuvry, Bordeaux, Boulogne-sur-Mer, Bron, Caen, Créteil
2017-05-03
Active, closed
AstraZeneca
Phase 3
987
Avignon, Brest, Créteil, La Tronche, Pierre-Bénite, Rennes
2017-03-27
Active, closed
National Cohort of Colorectal Cancers With Microsatellite Instability
NCT05511688Colorectal Cancer, Microsatellite Instability
Federation Francophone de Cancerologie Digestive
Observational
637
Poitiers, Abbeville, Amiens, Angers, Angoulême, Argenteuil, Auxerre, Avignon
2017-03-22
Active, closed
Management of Symptomatic Advanced Pancreatic Adenocarcinoma
NCT02979483Pancreas, Management Supportive Care Program
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicable
110
Avignon, Clichy, Créteil, Levallois-Perret, Lyon, Mont-de-Marsan, Paris, Thonon-les-Bains
2016-12-19
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
348
Angers, Antony, Avignon, Bayonne, Beauvais, Bordeaux, Caluire-et-Cuire, Challans
2016-12
Active, closed
Mouth Opening, Prevention, Education, Nutrition (OPEN)
NCT03979924Trismus, Head and Neck Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
175
Nîmes, Amiens, Avignon, Clermont-Ferrand, Montpellier, Saint-Pierre
2016-10-20
Active, closed
The Lymphoma Academic Research Organisation
Phase 1/2
214
Clermont-Ferrand, Argenteuil, Avignon, Besançon, Bordeaux, Chambéry, Créteil, Dijon
2016-10
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Amiens, Angers, Avignon, Bayonne, Besançon, Bordeaux, Brest, Dijon
2015-11-19
Recruiting
French Innovative Leukemia Organisation
Observational
1,000
Angers, Annecy, Avignon, Bayonne, Besançon, Brest, Clermont-Ferrand, Colmar
2015-01-06
Active, closed
AstraZeneca
Phase 3
1,837
Avignon, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dechy, La Roche-sur-Yon
2014-04-22
Active, closed
UNICANCER
Phase 2
1,460
Angers, Avignon, Bordeaux, Caen, Clermont-Ferrand, Dijon, La Roche-sur-Yon, Lille
2014-04-07
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
154
Villejuif, Avignon, Caen, Dijon, Lille, Marseille, Montpellier, Nice
2014-02-26
Active, closed
UNICANCER
Phase 3
1,173
Albi, Angers, Annecy, Avignon, Avranches, Bayonne, Besançon, Beuvry
2013-11-13
Active, closed
UNICANCER
Phase 2
120
Angers, Avignon, Besançon, Bordeaux, Brest, Caen, Chambéry, Créteil
2012-12
Recruiting
COsegregation of VARiants in Panel of Genes
NCT01689584Gene Mutation-Related Cancer, Genetic Predisposition
Institut Curie
Not applicable
11,000
Bastia, Saint-Cloud, Amiens, Angers, Angoulême, Avignon, Besançon, Bordeaux
2012-07-02
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Avignon, Bordeaux, Boulogne-Billancourt, Brest, Caen, Chambray, Clermont-Ferrand, Créteil
2012-01
Active, closed
Associazione Qol-one
Phase 2
174
Amiens, Avignon, Bayonne, Bobigny, Bordeaux, Boulogne-sur-Mer, Caen, Créteil
2011-06-11
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
5,018
Angers, Auch, Avignon, Bayonne, Beauvais, Blois, Bordeaux, Brest
2011-02-28
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2/3
574
Avignon, Besançon, Montbéliard, Strasbourg
2009-09
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1,649
Ambilly, Annecy, Aulnay-sous-Bois, Avignon, Bayonne, Besançon, Béziers, Bordeaux
1998-10
Recruiting
Medtronic
Observational
20,000
Avignon, Bayonne, Brest, Caen, Chambray-lès-Tours, Clermont-Ferrand, Dijon, La Rochelle
1983-01
Rows per page Showing 1–247 of 247
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/avignon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,698 studies in total at the last sync on 23 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 247 of those studies with a site in Avignon.

How many clinical trials are recruiting in Avignon?

116 of the 247 studies on this page are recruiting new participants as of the 23 Oct 2026, 03:20 UTC sync. A further 13 have not yet opened recruitment, 117 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Avignon), 247 studies
PhaseStudiesRecruitingShare
Phase 31054442.5%
Phase 2582323.5%
Not applicable362314.6%
Observational331913.4%
Phase 4833.2%
Phase 1/2421.6%
Phase 2/3210.8%
Phase 1110.4%

Most active sponsors

Lead sponsors with the most studies (Avignon)
Lead sponsorStudiesRecruiting
AstraZeneca2711
UNICANCER2715
The Lymphoma Academic Research Organisation113
Intergroupe Francophone de Cancerologie Thoracique84
Hoffmann-La Roche72
French Innovative Leukemia Organisation62
GERCOR - Multidisciplinary Oncology Cooperative Group61
Janssen Research & Development, LLC64
Merck Sharp & Dohme LLC62
ARCAGY/ GINECO GROUP52
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.